Journey Medical Q3 EPS $(0.05) Misses $(0.01) Estimate, Sales $18.967M Miss $20.321M Estimate
Benzinga Newsdesk 3 days ago
NewsEarningsEarnings Misses
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.01) by 400 percent. This is a 44.44 percent increase over losses of $(0.09) per share from
Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.01) by 400 percent. This is a 44.44 percent increase over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $18.967 million which missed the analyst consensus estimate of $20.321 million by 6.66 percent. This is a 7.58 percent increase over sales of $17.631 million the same period last year.
